WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
Position in NEO — Neogenomics Inc
CIK 1632972
PLYMOUTH, MN
Position in NEO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$597,343
+$479,967 QoQ
Shares Held
40,942
+158.8% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 47 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $184,108,370 across 28 Diagnostics & Research names. NEO ranks #18 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
93,673 | $46,963,895 | |
| 2 | DHR |
Danaher Corp /De/
|
139,461 | $26,564,531 | |
| 3 | ILMN |
Illumina, Inc.
|
107,790 | $18,952,715 | |
| 4 | LH |
Labcorp Holdings Inc.
|
56,094 | $15,706,320 | |
| 5 | NTRA |
Natera, Inc.
|
55,459 | $15,054,345 | |
| 6 | A |
Agilent Technologies, Inc.
|
103,978 | $13,811,397 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
15,922 | $8,432,131 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
42,028 | $8,120,650 |
All Filings in NEO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $597,343 | 40,942 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $117,376 | 15,819 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $130,536 | 11,100 | Shares | Sole | 2026-01-08 | |
| 2025-06-30 | $108,977 | 14,908 | Shares | Sole | 2025-07-10 | |
| No filing history on record for this holder in this stock. | ||||||